- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04862546
Laser Acupuncture Versus Tap Water Iontophoresis on Hyperhidrosis
Effect of Acupuncture Points Laser Versus Tap Water Iontophoresis on Hyperhidrosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kafr Ash Shaykh, Egypt, 12623
- Kafrelshaikh University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- volunteer subjects from MIT physical therapy students complained from hyperhidrosis examined by Hyperhidrosis Disease Severity Scale, Perceived Stress Scale.
Exclusion Criteria:
- Subjects will be excluded if they had musculoskeletal diseases and visceral disorders or had any operations or recent injury
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Laser Acupoint
Laser will be performed 3 times per week for 2-week measurement.
The duration of each cession will be 10 minutes treatment.
|
Step 1: The subject was in sitting position and exposure area for applying laser then therapist use tap measurement to find the point.
Parameters was used in this study : PROBE :ML A1\25 TIME:01:00 FREQUENCY: 10000Hz (25mw), DUTY-CYCLE:100% DENESITY: 1J\CM2 AREA :1CM2 Step 2: Apply laser on acupuncture points by using 10000HZ for 1 minute for every point.
Totally cession: 10 minutes Step 3: ensure that all point done Repeat all steps for every subject
|
Active Comparator: Tap water iontophoresis
Tap water iontophoresis will be performed 3 times per week for 2-weeks.
The duration of each cession will be 20 minutes treatment session.
|
Enough tap water is placed in the pans, then the generator is plugged in and switched on. After that, the patient's hands are placed in the pans. The treatment is administrated by slowly increased intensity to tell the patient to feel a tingling sensation or up to 20 milliamperes and continue with this polarity for 10 minutes. After that, the polarity reversed and intensity increased again to the desired level for another 10 minutes. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hyperhidrosis Disease Severity Scale
Time Frame: Change between baseline and 2 weeks of treatment measures
|
The Hyperhidrosis Disease Severity Scale (HDSS) is a disease-specific, quick, and easily-understood diagnostic tool that provides a qualitative measure of the severity of the patient's condition based on how it affects daily activities.
Ask the patient to select the statement above that best reflects his or her experience with sweating of the specified body area.
Next to each statement is a number.
A score of 3 or 4 indicates severe hyperhidrosis.
A score of 1 or 2 indicates mild or moderate hyperhidrosis.
|
Change between baseline and 2 weeks of treatment measures
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- LaserAcupuncture
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperhidrosis
-
Botanix PharmaceuticalsCompletedAxillary HyperhidrosisUnited States
-
miraDry, Inc.Withdrawn
-
Botanix PharmaceuticalsCompletedAxillary HyperhidrosisUnited States
-
Northwestern UniversityCompletedAxillary HyperhidrosisUnited States
-
Ulthera, IncCompletedAxillary HyperhidrosisGermany
-
Peking University People's HospitalBeijing Municipal Science & Technology CommissionCompleted
-
United States Naval Medical Center, San DiegoCandela Corp.Unknown
-
Tmaer Youssef MohamedCompletedPalmar Hyperhidrosis
-
Atacama TherapeuticsCompletedPalmar HyperhidrosisUnited States
-
Miramar LabsCompletedAxillary HyperhidrosisCanada
Clinical Trials on Laser Acupoint
-
Cairo UniversityRecruiting
-
Cairo UniversityRecruiting
-
Logan College of ChiropracticUnknown
-
Yueh-Lin HsuRecruiting
-
Hui-Yu LinRecruiting
-
China Medical University HospitalRecruitingCritically Ill PatientsTaiwan
-
Taipei Veterans General Hospital, TaiwanCompleted
-
West China HospitalCompletedThe Clinical Value of Acupoint SensitizationChina
-
Peking University Cancer Hospital & InstituteRecruiting
-
Shanghai Municipal Hospital of Traditional Chinese...Recruiting